tiprankstipranks
Trending News
More News >
VentriPoint Diagnostics Ltd (TSE:VPT)
:VPT
Advertisement

VentriPoint Diagnostics (VPT) Price & Analysis

Compare
31 Followers

VPT Stock Chart & Stats


VentriPoint Diagnostics News

VPT FAQ

What was VentriPoint Diagnostics Ltd’s price range in the past 12 months?
VentriPoint Diagnostics Ltd lowest stock price was C$0.07 and its highest was C$0.20 in the past 12 months.
    What is VentriPoint Diagnostics Ltd’s market cap?
    VentriPoint Diagnostics Ltd’s market cap is C$17.61M.
      When is VentriPoint Diagnostics Ltd’s upcoming earnings report date?
      VentriPoint Diagnostics Ltd’s upcoming earnings report date is Nov 26, 2025 which is in 59 days.
        How were VentriPoint Diagnostics Ltd’s earnings last quarter?
        VentriPoint Diagnostics Ltd released its earnings results on Aug 29, 2025. The company reported -C$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.008.
          Is VentriPoint Diagnostics Ltd overvalued?
          According to Wall Street analysts VentriPoint Diagnostics Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does VentriPoint Diagnostics Ltd pay dividends?
            VentriPoint Diagnostics Ltd does not currently pay dividends.
            What is VentriPoint Diagnostics Ltd’s EPS estimate?
            VentriPoint Diagnostics Ltd’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does VentriPoint Diagnostics Ltd have?
            VentriPoint Diagnostics Ltd has 167,704,010 shares outstanding.
              What happened to VentriPoint Diagnostics Ltd’s price movement after its last earnings report?
              VentriPoint Diagnostics Ltd reported an EPS of -C$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of VentriPoint Diagnostics Ltd?
                Currently, no hedge funds are holding shares in TSE:VPT

                VentriPoint Diagnostics Stock Smart Score

                5
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -36.36%
                12-Months-Change

                Fundamentals

                Return on Equity
                207.08%
                Trailing 12-Months
                Asset Growth
                -21.46%
                Trailing 12-Months

                Company Description

                VentriPoint Diagnostics Ltd

                VentriPoint Diagnostics (VPT) is a medical device company specializing in developing advanced imaging solutions for cardiac diagnostics. The company is focused on improving the assessment of heart function using its proprietary technology that enables accurate and efficient three-dimensional visualization of the heart. VentriPoint's core product, the VMS+ system, offers a non-invasive, cost-effective alternative to traditional imaging methods, aiming to enhance patient care and streamline the diagnostic process in cardiology.

                VentriPoint Diagnostics (VPT) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Aurora Spine
                Perimeter Medical Imaging AI
                Quipt Home Medical
                Profound Medical
                Theralase Technologies

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis